abstract |
The present invention generally relates to the treatment of diseases and pathological conditions using anti-VEGF antibodies. More particularly, the present invention relates to the use of an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapies, to treat ovarian cancer and to treat human patients susceptible to cancer or diagnosed with cancer will be. |